• +1-646-491-9876
    • +91-20-67278686

    Search

    Alzheimer's Disease - Pipeline Review, H1 2017

    Alzheimer's Disease - Pipeline Review, H1 2017

    • Report Code ID: RW0001709487
    • Category Pharmaceuticals
    • No. of Pages 1181
    • Publication Month Mar-17
    • Publisher Name Global Markets Direct
    Alzheimer's Disease - Pipeline Review, H1 2017

    Summary

    Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Alzheimer's Disease - Pipeline Review, H1 2017, provides an overview of the Alzheimer's Disease (Central Nervous System) pipeline landscape.

    Alzheimer's disease is a progressive, degenerative condition causing damage to the memory and behavior due to the attack on the neurons. These neurons are responsible for the synthesis of neurotransmitter acetylcholine which is further responsible for the transmission of signals. Predisposing factors include age, heredity, cardiovascular diseases or diabetes and environmental factors. Symptoms include depression, anxiety, social withdrawal, irritability and aggressiveness.

    Report Highlights

    Publisher's Pharmaceutical and Healthcare latest pipeline guide Alzheimer's Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Alzheimer's Disease (Central Nervous System) , complete with analysis by stage of development, drug target, mechanism of action (MoA) , route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

    The Alzheimer's Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Alzheimer's Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 1, 23, 40, 62, 1, 251, 90 and 5 respectively. Similarly, the Universities portfolio in Phase II, Preclinical and Discovery stages comprises 1, 109 and 46 molecules, respectively.

    Alzheimer's Disease (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

    Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

    Scope

    - The pipeline guide provides a snapshot of the global therapeutic landscape of Alzheimer's Disease (Central Nervous System) .
    - The pipeline guide reviews pipeline therapeutics for Alzheimer's Disease (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
    - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
    - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
    - The pipeline guide reviews key companies involved in Alzheimer's Disease (Central Nervous System) therapeutics and enlists all their major and minor projects.
    - The pipeline guide evaluates Alzheimer's Disease (Central Nervous System) therapeutics based on mechanism of action (MoA) , drug target, route of administration (RoA) and molecule type.
    - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
    - The pipeline guide reviews latest news related to pipeline therapeutics for Alzheimer's Disease (Central Nervous System)

    Reasons to buy

    - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
    - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
    - Find and recognize significant and varied types of therapeutics under development for Alzheimer's Disease (Central Nervous System) .
    - Classify potential new clients or partners in the target demographic.
    - Develop tactical initiatives by understanding the focus areas of leading companies.
    - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
    - Formulate corrective measures for pipeline projects by understanding Alzheimer's Disease (Central Nervous System) pipeline depth and focus of Indication therapeutics.
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
    - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
    Table of Contents 2
    Introduction 12
    Alzheimer's Disease - Overview 13
    Alzheimer's Disease - Therapeutics Development 14
    Alzheimer's Disease - Therapeutics Assessment 78
    Alzheimer's Disease - Companies Involved in Therapeutics Development 102
    Alzheimer's Disease - Drug Profiles 218
    Alzheimer's Disease - Dormant Projects 1072
    Alzheimer's Disease - Discontinued Products 1102
    Alzheimer's Disease - Product Development Milestones 1108
    Appendix 1118

    List of Tables

    Number of Products under Development for Alzheimer's Disease, H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..1) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..2) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..3) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..4) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..5) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..6) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..7) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..8) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..9) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..10) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..11) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..12) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..13) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..14) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..15) , H1 2017
    Number of Products under Development by Universities/Institutes, H1 2017
    Number of Products under Development by Universities/Institutes, H1 2017 (Contd..1) , H1 2017
    Number of Products under Development by Universities/Institutes, H1 2017 (Contd..2) , H1 2017
    Number of Products under Development by Universities/Institutes, H1 2017 (Contd..3) , H1 2017
    Number of Products under Development by Universities/Institutes, H1 2017 (Contd..4) , H1 2017
    Number of Products under Development by Universities/Institutes, H1 2017 (Contd..5) , H1 2017
    Products under Development by Companies, H1 2017
    Products under Development by Companies, H1 2017 (Contd..1) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..2) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..3) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..4) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..5) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..6) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..7) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..8) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..9) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..10) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..11) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..12) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..13) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..14) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..15) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..16) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..17) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..18) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..19) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..20) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..21) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..22) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..23) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..24) , H1 2017
    Products under Development by Universities/Institutes, H1 2017
    Products under Development by Universities/Institutes, H1 2017 (Contd..1) , H1 2017
    Products under Development by Universities/Institutes, H1 2017 (Contd..2) , H1 2017
    Products under Development by Universities/Institutes, H1 2017 (Contd..3) , H1 2017
    Products under Development by Universities/Institutes, H1 2017 (Contd..4) , H1 2017
    Products under Development by Universities/Institutes, H1 2017 (Contd..5) , H1 2017
    Products under Development by Universities/Institutes, H1 2017 (Contd..6) , H1 2017
    Products under Development by Universities/Institutes, H1 2017 (Contd..7) , H1 2017
    Number of Products by Stage and Target, H1 2017
    Number of Products by Stage and Target, H1 2017 (Contd..1) , H1 2017
    Number of Products by Stage and Target, H1 2017 (Contd..2) , H1 2017
    Number of Products by Stage and Target, H1 2017 (Contd..3) , H1 2017
    Number of Products by Stage and Target, H1 2017 (Contd..4) , H1 2017
    Number of Products by Stage and Target, H1 2017 (Contd..5) , H1 2017
    Number of Products by Stage and Target, H1 2017 (Contd..6) , H1 2017
    Number of Products by Stage and Target, H1 2017 (Contd..7) , H1 2017
    Number of Products by Stage and Target, H1 2017 (Contd..8) , H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..1) , H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..2) , H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..3) , H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..4) , H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..5) , H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..6) , H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..7) , H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..8) , H1 2017
    Number of Products by Stage and Route of Administration, H1 2017
    Number of Products by Stage and Molecule Type, H1 2017
    Alzheimer's Disease - Pipeline by AB Science SA, H1 2017
    Alzheimer's Disease - Pipeline by AbbVie Inc, H1 2017
    Alzheimer's Disease - Pipeline by AC Immune SA, H1 2017
    Alzheimer's Disease - Pipeline by Acadia Pharmaceuticals Inc, H1 2017
    Alzheimer's Disease - Pipeline by Accera Inc, H1 2017
    Alzheimer's Disease - Pipeline by Acelot Inc, H1 2017
    Alzheimer's Disease - Pipeline by Actinogen Medical Ltd, H1 2017
    Alzheimer's Disease - Pipeline by Acumen Pharmaceuticals Inc, H1 2017
    Alzheimer's Disease - Pipeline by Addex Therapeutics Ltd, H1 2017
    Alzheimer's Disease - Pipeline by Affibody AB, H1 2017
    Alzheimer's Disease - Pipeline by AFFiRiS AG, H1 2017
    Alzheimer's Disease - Pipeline by Alector LLC, H1 2017
    Alzheimer's Disease - Pipeline by Allergan Plc, H1 2017
    Alzheimer's Disease - Pipeline by Allinky Biopharma, H1 2017
    Alzheimer's Disease - Pipeline by ALSP Inc, H1 2017
    Alzheimer's Disease - Pipeline by Alzhyme Pty Ltd, H1 2017
    Alzheimer's Disease - Pipeline by Alzinova AB, H1 2017
    Alzheimer's Disease - Pipeline by AlzProtect SAS, H1 2017
    Alzheimer's Disease - Pipeline by Amarantus Bioscience Holdings Inc, H1 2017
    Alzheimer's Disease - Pipeline by Amgen Inc, H1 2017
    Alzheimer's Disease - Pipeline by Anavex Life Sciences Corp, H1 2017
    Alzheimer's Disease - Pipeline by Annexon Inc, H1 2017
    Alzheimer's Disease - Pipeline by Aphios Corp, H1 2017
    Alzheimer's Disease - Pipeline by Apodemus AB, H1 2017
    Alzheimer's Disease - Pipeline by Applied Research using OMIC Sciences SL, H1 2017
    Alzheimer's Disease - Pipeline by Aptevo Therapeutics Inc, H1 2017
    Alzheimer's Disease - Pipeline by Araclon Biotech SL, H1 2017
    Alzheimer's Disease - Pipeline by Archer Pharmaceuticals Inc, H1 2017
    Alzheimer's Disease - Pipeline by ArmaGen Inc, H1 2017
    Alzheimer's Disease - Pipeline by Artery Therapeutics Inc, H1 2017
    Alzheimer's Disease - Pipeline by Asceneuron SA, H1 2017
    Alzheimer's Disease - Pipeline by AskAt Inc, H1 2017
    Alzheimer's Disease - Pipeline by Astellas Pharma Inc, H1 2017
    Alzheimer's Disease - Pipeline by AstraZeneca Plc, H1 2017
    Alzheimer's Disease - Pipeline by Asubio Pharma Co Ltd, H1 2017
    Alzheimer's Disease - Pipeline by Avineuro Pharmaceuticals Inc, H1 2017
    Alzheimer's Disease - Pipeline by Axon Neuroscience SE, H1 2017
    Alzheimer's Disease - Pipeline by Axovant Sciences Ltd., H1 2017
    Alzheimer's Disease - Pipeline by Axxam SpA, H1 2017
    Alzheimer's Disease - Pipeline by Beactica AB, H1 2017
    Alzheimer's Disease - Pipeline by Berg LLC, H1 2017
    Alzheimer's Disease - Pipeline by BioArtic AB, H1 2017
    Alzheimer's Disease - Pipeline by Bioasis Technologies Inc, H1 2017
    Alzheimer's Disease - Pipeline by Biogen Inc, H1 2017
    Alzheimer's Disease - Pipeline by BioHealthonomics Inc, H1 2017
    Alzheimer's Disease - Pipeline by Biomar Microbial Technologies, H1 2017
    Alzheimer's Disease - Pipeline by Boehringer Ingelheim GmbH, H1 2017
    Alzheimer's Disease - Pipeline by Boryung Pharmaceutical Co Ltd, H1 2017
    Alzheimer's Disease - Pipeline by Bristol-Myers Squibb Company, H1 2017
    Alzheimer's Disease - Pipeline by Bsim2, H1 2017
    Alzheimer's Disease - Pipeline by Cantabio Pharmaceuticals Inc, H1 2017
    Alzheimer's Disease - Pipeline by Cardax Inc, H1 2017
    Alzheimer's Disease - Pipeline by Carna Biosciences Inc, H1 2017
    Alzheimer's Disease - Pipeline by Celon Pharma SA, H1 2017
    Alzheimer's Disease - Pipeline by CHA Bio & Diostech Co Ltd, H1 2017
    Alzheimer's Disease - Pipeline by Clera Inc, H1 2017
    Alzheimer's Disease - Pipeline by Cognition Therapeutics Inc, H1 2017
    Alzheimer's Disease - Pipeline by Cognosci Inc, H1 2017
    Alzheimer's Disease - Pipeline by CohBar Inc, H1 2017
    Alzheimer's Disease - Pipeline by Connexios Life Sciences Pvt Ltd, H1 2017
    Alzheimer's Disease - Pipeline by ContraVir Pharmaceuticals Inc, H1 2017
    Alzheimer's Disease - Pipeline by Corium International Inc, H1 2017
    Alzheimer's Disease - Pipeline by Coronis NeuroSciences Ltd, H1 2017
    Alzheimer's Disease - Pipeline by Cortice Biosciences Inc, H1 2017
    Alzheimer's Disease - Pipeline by Critical Outcome Technologies Inc, H1 2017
    Alzheimer's Disease - Pipeline by Crossbeta Biosciences BV, H1 2017
    Alzheimer's Disease - Pipeline by Daewoong Pharmaceutical Co Ltd, H1 2017
    Alzheimer's Disease - Pipeline by Daiichi Sankyo Company Ltd, H1 2017
    Alzheimer's Disease - Pipeline by Daval International Ltd, H1 2017
    Alzheimer's Disease - Pipeline by Denali Therapeutics Inc, H1 2017
    Alzheimer's Disease - Pipeline by DermaXon LLC, H1 2017
    Alzheimer's Disease - Pipeline by Domain Therapeutics SA, H1 2017
    Alzheimer's Disease - Pipeline by Dongkook Pharmaceutical Co Ltd, H1 2017
    Alzheimer's Disease - Pipeline by Eisai Co Ltd, H1 2017
    Alzheimer's Disease - Pipeline by Eli Lilly and Company, H1 2017
    Alzheimer's Disease - Pipeline by EncephRx Inc, H1 2017
    Alzheimer's Disease - Pipeline by Endece LLC, H1 2017
    Alzheimer's Disease - Pipeline by ENKAM Pharmaceuticals A/S, H1 2017
    Alzheimer's Disease - Pipeline by Ensemble Therapeutics Corp, H1 2017
    Alzheimer's Disease - Pipeline by Ensol Biosciences Inc, H1 2017
    Alzheimer's Disease - Pipeline by Epigen Biosciences Inc, H1 2017
    Alzheimer's Disease - Pipeline by Evotec AG, H1 2017
    Alzheimer's Disease - Pipeline by F. Hoffmann-La Roche Ltd, H1 2017
    Alzheimer's Disease - Pipeline by Genentech Inc, H1 2017
    Alzheimer's Disease - Pipeline by Genervon Biopharmaceuticals LLC, H1 2017
    Alzheimer's Disease - Pipeline by Genzyme Corp, H1 2017
    Alzheimer's Disease - Pipeline by GlaxoSmithKline Plc, H1 2017
    Alzheimer's Disease - Pipeline by GliaCure Inc, H1 2017
    Alzheimer's Disease - Pipeline by Glialogix Inc, H1 2017
    Alzheimer's Disease - Pipeline by Golden Biotechnology Corp, H1 2017
    Alzheimer's Disease - Pipeline by Grifols SA, H1 2017
    Alzheimer's Disease - Pipeline by H. Lundbeck A/S, H1 2017
    Alzheimer's Disease - Pipeline by Heptares Therapeutics Ltd, H1 2017
    Alzheimer's Disease - Pipeline by HitGen LTD, H1 2017
    Alzheimer's Disease - Pipeline by HSRx Group, H1 2017
    Alzheimer's Disease - Pipeline by ICB International Inc, H1 2017
    Alzheimer's Disease - Pipeline by Ichor Medical Systems Inc, H1 2017
    Alzheimer's Disease - Pipeline by Icure Pharmaceutical Inc, H1 2017
    Alzheimer's Disease - Pipeline by Immungenetics AG, H1 2017
    Alzheimer's Disease - Pipeline by Impel NeuroPharma Inc, H1 2017
    Alzheimer's Disease - Pipeline by ImStar Therapeutics Inc, H1 2017
    Alzheimer's Disease - Pipeline by Inovio Pharmaceuticals Inc, H1 2017
    Alzheimer's Disease - Pipeline by IntelGenx Corp, H1 2017
    Alzheimer's Disease - Pipeline by Intellect Neurosciences Inc, H1 2017
    Alzheimer's Disease - Pipeline by Intra-Cellular Therapies Inc, H1 2017
    Alzheimer's Disease - Pipeline by INVENT Pharmaceuticals Inc, H1 2017
    Alzheimer's Disease - Pipeline by Io Therapeutics Inc, H1 2017
    Alzheimer's Disease - Pipeline by Ironwood Pharmaceuticals Inc, H1 2017
    Alzheimer's Disease - Pipeline by Jeil Pharmaceutical Co Ltd, H1 2017
    Alzheimer's Disease - Pipeline by Jiangsu Kanion Pharmaceutical Co Ltd, H1 2017
    Alzheimer's Disease - Pipeline by Johnson & Johnson, H1 2017
    Alzheimer's Disease - Pipeline by K-Stemcell Co Ltd, H1 2017
    Alzheimer's Disease - Pipeline by Kadmon Corp LLC, H1 2017
    Alzheimer's Disease - Pipeline by Kalgene Pharmaceuticals Inc, H1 2017
    Alzheimer's Disease - Pipeline by Kareus Therapeutics SA, H1 2017
    Alzheimer's Disease - Pipeline by Karuna Pharmaceuticals Inc, H1 2017
    Alzheimer's Disease - Pipeline by KineMed Inc, H1 2017
    Alzheimer's Disease - Pipeline by Krenitsky Pharmaceuticals Inc, H1 2017
    Alzheimer's Disease - Pipeline by Kyowa Hakko Kirin Co Ltd, H1 2017
    Alzheimer's Disease - Pipeline by Lead Discovery Center GmbH, H1 2017
    Alzheimer's Disease - Pipeline by Les Laboratoires Servier SAS, H1 2017
    Alzheimer's Disease - Pipeline by Lipopharma Therapeutics SL, H1 2017
    Alzheimer's Disease - Pipeline by Living Cell Technologies Ltd, H1 2017
    Alzheimer's Disease - Pipeline by Lupin Ltd, H1 2017
    Alzheimer's Disease - Pipeline by M3 Biotechnology Inc, H1 2017
    Alzheimer's Disease - Pipeline by ManRos Therapeutics, H1 2017
    Alzheimer's Disease - Pipeline by MedDay SA, H1 2017
    Alzheimer's Disease - Pipeline by Medestea Research & Production SpA, H1 2017
    Alzheimer's Disease - Pipeline by MedImmune LLC, H1 2017
    Alzheimer's Disease - Pipeline by Medisyn Technologies Inc, H1 2017
    Alzheimer's Disease - Pipeline by MEDRx Co Ltd, H1 2017
    Alzheimer's Disease - Pipeline by MEI Pharma Inc, H1 2017
    Alzheimer's Disease - Pipeline by MeiraGTx Ltd, H1 2017
    Alzheimer's Disease - Pipeline by Merck & Co Inc, H1 2017
    Alzheimer's Disease - Pipeline by Metabolic Solutions Development Company LLC, H1 2017
    Alzheimer's Disease - Pipeline by Microlin Bio Inc, H1 2017
    Alzheimer's Disease - Pipeline by Mithridion Inc, H1 2017
    Alzheimer's Disease - Pipeline by Mitochon Pharmaceuticals Inc, H1 2017
    Alzheimer's Disease - Pipeline by Mitsubishi Tanabe Pharma Corp, H1 2017
    Alzheimer's Disease - Pipeline by ModGene Pharma LLC, H1 2017
    Alzheimer's Disease - Pipeline by NAL Pharmaceuticals Ltd, H1 2017
    Alzheimer's Disease - Pipeline by Nanomerics Ltd, H1 2017
    Alzheimer's Disease - Pipeline by Nanotherapeutics Inc, H1 2017
    Alzheimer's Disease - Pipeline by Neuralstem Inc, H1 2017
    Alzheimer's Disease - Pipeline by Neuraltus Pharmaceuticals Inc, H1 2017
    Alzheimer's Disease - Pipeline by Neurim Pharmaceuticals Ltd, H1 2017
    Alzheimer's Disease - Pipeline by Neuro-Sys SAS, H1 2017
    Alzheimer's Disease - Pipeline by NeuroGenetic Pharmaceuticals Inc, H1 2017
    Alzheimer's Disease - Pipeline by NeuroNascent Inc, H1 2017
    Alzheimer's Disease - Pipeline by NeurOp Inc, H1 2017
    Alzheimer's Disease - Pipeline by Neuropore Therapies Inc, H1 2017
    Alzheimer's Disease - Pipeline by Neurotez Inc, H1 2017
    Alzheimer's Disease - Pipeline by New World Laboratories Inc, H1 2017
    Alzheimer's Disease - Pipeline by nLife Therapeutics SL, H1 2017
    Alzheimer's Disease - Pipeline by NLS Pharma Group, H1 2017
    Alzheimer's Disease - Pipeline by Novartis AG, H1 2017
    Alzheimer's Disease - Pipeline by NsGene A/S, H1 2017
    Alzheimer's Disease - Pipeline by Oligomerix inc, H1 2017
    Alzheimer's Disease - Pipeline by Orphit SAS, H1 2017
    Alzheimer's Disease - Pipeline by Oryzon Genomics SA, H1 2017
    Alzheimer's Disease - Pipeline by P2D Bioscience, H1 2017
    Alzheimer's Disease - Pipeline by Pain Therapeutics Inc, H1 2017
    Alzheimer's Disease - Pipeline by Palumed SA, H1 2017
    Alzheimer's Disease - Pipeline by Panacea Pharmaceuticals Inc, H1 2017
    Alzheimer's Disease - Pipeline by Peptron Inc, H1 2017
    Alzheimer's Disease - Pipeline by Pfizer Inc, H1 2017
    Alzheimer's Disease - Pipeline by PharmaKure Ltd, H1 2017
    Alzheimer's Disease - Pipeline by PharmatrophiX Inc, H1 2017
    Alzheimer's Disease - Pipeline by Pharmaxis Ltd, H1 2017
    Alzheimer's Disease - Pipeline by Pharnext SA, H1 2017
    Alzheimer's Disease - Pipeline by Prevacus Inc, H1 2017
    Alzheimer's Disease - Pipeline by Probiodrug AG, H1 2017
    Alzheimer's Disease - Pipeline by Proclara Biosciences Inc, H1 2017
    Alzheimer's Disease - Pipeline by Progenra Inc, H1 2017
    Alzheimer's Disease - Pipeline by ProMIS Neurosciences Inc, H1 2017
    Alzheimer's Disease - Pipeline by ProQR Therapeutics NV, H1 2017
    Alzheimer's Disease - Pipeline by Proteome Sciences Plc, H1 2017
    Alzheimer's Disease - Pipeline by Proteostasis Therapeutics Inc, H1 2017
    Alzheimer's Disease - Pipeline by QR Pharma Inc, H1 2017
    Alzheimer's Disease - Pipeline by Quimatryx SL, H1 2017
    Alzheimer's Disease - Pipeline by Radius Health Inc, H1 2017
    Alzheimer's Disease - Pipeline by Regenera Pharma Ltd, H1 2017
    Alzheimer's Disease - Pipeline by reMYND NV, H1 2017
    Alzheimer's Disease - Pipeline by Resverlogix Corp, H1 2017
    Alzheimer's Disease - Pipeline by Retrotope Inc, H1 2017
    Alzheimer's Disease - Pipeline by ReXceptor Inc, H1 2017
    Alzheimer's Disease - Pipeline by Rodos BioTarget GmbH, H1 2017
    Alzheimer's Disease - Pipeline by Sage Therapeutics Inc, H1 2017
    Alzheimer's Disease - Pipeline by Samjin Pharmaceutical Co Ltd, H1 2017
    Alzheimer's Disease - Pipeline by Samumed LLC, H1 2017
    Alzheimer's Disease - Pipeline by SanBio Inc, H1 2017
    Alzheimer's Disease - Pipeline by Saneron CCEL Therapeutics Inc, H1 2017
    Alzheimer's Disease - Pipeline by Sanofi, H1 2017
    Alzheimer's Disease - Pipeline by SBI Pharmaceuticals Co Ltd, H1 2017
    Alzheimer's Disease - Pipeline by Selvita SA, H1 2017
    Alzheimer's Disease - Pipeline by SeneXta Therapeutics SA, H1 2017
    Alzheimer's Disease - Pipeline by Serometrix LLC, H1 2017
    Alzheimer's Disease - Pipeline by Signum Biosciences Inc, H1 2017
    Alzheimer's Disease - Pipeline by Simcere Pharmaceutical Group, H1 2017
    Alzheimer's Disease - Pipeline by SK Biopharmaceuticals Co Ltd, H1 2017
    Alzheimer's Disease - Pipeline by SOM Biotech SL, H1 2017
    Alzheimer's Disease - Pipeline by Spectrum Pharmaceuticals Inc, H1 2017
    Alzheimer's Disease - Pipeline by Spherium Biomed SL, H1 2017
    Alzheimer's Disease - Pipeline by Stemedica Cell Technologies Inc, H1 2017
    Alzheimer's Disease - Pipeline by Sumitomo Dainippon Pharma Co Ltd, H1 2017
    Alzheimer's Disease - Pipeline by Summit Therapeutics Plc, H1 2017
    Alzheimer's Disease - Pipeline by Suven Life Sciences Ltd, H1 2017
    Alzheimer's Disease - Pipeline by T3D Therapeutics Inc, H1 2017
    Alzheimer's Disease - Pipeline by Takeda Pharmaceutical Company Ltd, H1 2017
    Alzheimer's Disease - Pipeline by TauRx Therapeutics Ltd, H1 2017
    Alzheimer's Disease - Pipeline by TechnoPhage SA, H1 2017
    Alzheimer's Disease - Pipeline by Teijin Pharma Ltd, H1 2017
    Alzheimer's Disease - Pipeline by Teikoku Pharma USA Inc, H1 2017
    Alzheimer's Disease - Pipeline by Telocyte LLC, H1 2017
    Alzheimer's Disease - Pipeline by Tetra Discovery Partners LLC, H1 2017
    Alzheimer's Disease - Pipeline by Thera Neuropharma Inc, H1 2017
    Alzheimer's Disease - Pipeline by Theranexus SAS, H1 2017
    Alzheimer's Disease - Pipeline by Therapix Biosciences Ltd, H1 2017
    Alzheimer's Disease - Pipeline by Toyama Chemical Co Ltd, H1 2017
    Alzheimer's Disease - Pipeline by Treventis Corp, H1 2017
    Alzheimer's Disease - Pipeline by UCB SA, H1 2017
    Alzheimer's Disease - Pipeline by Varinel Inc, H1 2017
    Alzheimer's Disease - Pipeline by Virobay Inc, H1 2017
    Alzheimer's Disease - Pipeline by Vitae Pharmaceuticals Inc, H1 2017
    Alzheimer's Disease - Pipeline by VLP Therapeutics LLC, H1 2017
    Alzheimer's Disease - Pipeline by Voyager Therapeutics Inc, H1 2017
    Alzheimer's Disease - Pipeline by vTv Therapeutics Inc, H1 2017
    Alzheimer's Disease - Pipeline by Vybion Inc, H1 2017
    Alzheimer's Disease - Pipeline by Wellstat Therapeutics Corp, H1 2017
    Alzheimer's Disease - Pipeline by Xigen SA, H1 2017
    Alzheimer's Disease - Pipeline by Zhejiang Hisun Pharmaceutical Co Ltd, H1 2017
    Alzheimer's Disease - Dormant Projects, H1 2017
    Alzheimer's Disease - Dormant Projects, H1 2017 (Contd..1) , H1 2017
    Alzheimer's Disease - Dormant Projects, H1 2017 (Contd..2) , H1 2017
    Alzheimer's Disease - Dormant Projects, H1 2017 (Contd..3) , H1 2017
    Alzheimer's Disease - Dormant Projects, H1 2017 (Contd..4) , H1 2017
    Alzheimer's Disease - Dormant Projects, H1 2017 (Contd..5) , H1 2017
    Alzheimer's Disease - Dormant Projects, H1 2017 (Contd..6) , H1 2017
    Alzheimer's Disease - Dormant Projects, H1 2017 (Contd..7) , H1 2017
    Alzheimer's Disease - Dormant Projects, H1 2017 (Contd..8) , H1 2017
    Alzheimer's Disease - Dormant Projects, H1 2017 (Contd..9) , H1 2017
    Alzheimer's Disease - Dormant Projects, H1 2017 (Contd..10) , H1 2017
    Alzheimer's Disease - Dormant Projects, H1 2017 (Contd..11) , H1 2017
    Alzheimer's Disease - Dormant Projects, H1 2017 (Contd..12) , H1 2017
    Alzheimer's Disease - Dormant Projects, H1 2017 (Contd..13) , H1 2017
    Alzheimer's Disease - Dormant Projects, H1 2017 (Contd..14) , H1 2017
    Alzheimer's Disease - Dormant Projects, H1 2017 (Contd..15) , H1 2017
    Alzheimer's Disease - Dormant Projects, H1 2017 (Contd..16) , H1 2017
    Alzheimer's Disease - Dormant Projects, H1 2017 (Contd..17) , H1 2017
    Alzheimer's Disease - Dormant Projects, H1 2017 (Contd..18) , H1 2017
    Alzheimer's Disease - Dormant Projects, H1 2017 (Contd..19) , H1 2017
    Alzheimer's Disease - Dormant Projects, H1 2017 (Contd..20) , H1 2017
    Alzheimer's Disease - Dormant Projects, H1 2017 (Contd..21) , H1 2017
    Alzheimer's Disease - Dormant Projects, H1 2017 (Contd..22) , H1 2017
    Alzheimer's Disease - Dormant Projects, H1 2017 (Contd..23) , H1 2017
    Alzheimer's Disease - Dormant Projects, H1 2017 (Contd..24) , H1 2017
    Alzheimer's Disease - Dormant Projects, H1 2017 (Contd..25) , H1 2017
    Alzheimer's Disease - Discontinued Products, H1 2017
    Alzheimer's Disease - Discontinued Products, H1 2017 (Contd..1) , H1 2017
    Alzheimer's Disease - Discontinued Products, H1 2017 (Contd..2) , H1 2017
    Alzheimer's Disease - Discontinued Products, H1 2017 (Contd..3) , H1 2017
    Alzheimer's Disease - Discontinued Products, H1 2017 (Contd..4) , H1 2017
    Alzheimer's Disease - Discontinued Products, H1 2017 (Contd..5) , H1 2017

    List of Figures

    Number of Products under Development for Alzheimer's Disease, H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products under Development by Universities/Institutes, H1 2017
    Number of Products by Top 10 Targets, H1 2017
    Number of Products by Stage and Top 10 Targets, H1 2017
    Number of Products by Top 10 Mechanism of Actions, H1 2017
    Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
    Number of Products by Top 10 Routes of Administration, H1 2017
    Number of Products by Stage and Top 10 Routes of Administration, H1 2017
    Number of Products by Top 10 Molecule Types, H1 2017
    Number of Products by Stage and Top 10 Molecule Types, H1 2017
    AB Science SA
    AbbVie Inc
    AC Immune SA
    Acadia Pharmaceuticals Inc
    Accera Inc
    Acelot Inc
    Actinogen Medical Ltd
    Acumen Pharmaceuticals Inc
    Addex Therapeutics Ltd
    Affibody AB
    AFFiRiS AG
    Alector LLC
    Allergan Plc
    Allinky Biopharma
    ALSP Inc
    Alzhyme Pty Ltd
    Alzinova AB
    AlzProtect SAS
    Amarantus Bioscience Holdings Inc
    Amgen Inc
    Anavex Life Sciences Corp
    Annexon Inc
    Aphios Corp
    Apodemus AB
    Applied Research using OMIC Sciences SL
    Aptevo Therapeutics Inc
    Araclon Biotech SL
    Archer Pharmaceuticals Inc
    ArmaGen Inc
    Artery Therapeutics Inc
    Asceneuron SA
    AskAt Inc
    Astellas Pharma Inc
    AstraZeneca Plc
    Asubio Pharma Co Ltd
    Avineuro Pharmaceuticals Inc
    Axon Neuroscience SE
    Axovant Sciences Ltd.
    Axxam SpA
    Beactica AB
    Berg LLC
    BioArtic AB
    Bioasis Technologies Inc
    Biogen Inc
    BioHealthonomics Inc
    Biomar Microbial Technologies
    Boehringer Ingelheim GmbH
    Boryung Pharmaceutical Co Ltd
    Bristol-Myers Squibb Company
    Bsim2
    Cantabio Pharmaceuticals Inc
    Cardax Inc
    Carna Biosciences Inc
    Celon Pharma SA
    CHA Bio & Diostech Co Ltd
    Clera Inc
    Cognition Therapeutics Inc
    Cognosci Inc
    CohBar Inc
    Connexios Life Sciences Pvt Ltd
    ContraVir Pharmaceuticals Inc
    Corium International Inc
    Coronis NeuroSciences Ltd
    Cortice Biosciences Inc
    Critical Outcome Technologies Inc
    Crossbeta Biosciences BV
    Daewoong Pharmaceutical Co Ltd
    Daiichi Sankyo Company Ltd
    Daval International Ltd
    Denali Therapeutics Inc
    DermaXon LLC
    Domain Therapeutics SA
    Dongkook Pharmaceutical Co Ltd
    Eisai Co Ltd
    Eli Lilly and Company
    EncephRx Inc
    Endece LLC
    ENKAM Pharmaceuticals A/S
    Ensemble Therapeutics Corp
    Ensol Biosciences Inc
    Epigen Biosciences Inc
    Evotec AG
    F. Hoffmann-La Roche Ltd
    Genentech Inc
    Genervon Biopharmaceuticals LLC
    Genzyme Corp
    GlaxoSmithKline Plc
    GliaCure Inc
    Glialogix Inc
    Golden Biotechnology Corp
    Grifols SA
    H. Lundbeck A/S
    Heptares Therapeutics Ltd
    HitGen LTD
    HSRx Group
    ICB International Inc
    Ichor Medical Systems Inc
    Icure Pharmaceutical Inc
    Immungenetics AG
    Impel NeuroPharma Inc
    ImStar Therapeutics Inc
    Inovio Pharmaceuticals Inc
    IntelGenx Corp
    Intellect Neurosciences Inc
    Intra-Cellular Therapies Inc
    INVENT Pharmaceuticals Inc
    Io Therapeutics Inc
    Ironwood Pharmaceuticals Inc
    Jeil Pharmaceutical Co Ltd
    Jiangsu Kanion Pharmaceutical Co Ltd
    Johnson & Johnson
    K-Stemcell Co Ltd
    Kadmon Corp LLC
    Kalgene Pharmaceuticals Inc
    Kareus Therapeutics SA
    Karuna Pharmaceuticals Inc
    KineMed Inc
    Krenitsky Pharmaceuticals Inc
    Kyowa Hakko Kirin Co Ltd
    Lead Discovery Center GmbH
    Les Laboratoires Servier SAS
    Lipopharma Therapeutics SL
    Living Cell Technologies Ltd
    Lupin Ltd
    M3 Biotechnology Inc
    ManRos Therapeutics
    MedDay SA
    Medestea Research & Production SpA
    MedImmune LLC
    Medisyn Technologies Inc
    MEDRx Co Ltd
    MEI Pharma Inc
    MeiraGTx Ltd
    Merck & Co Inc
    Metabolic Solutions Development Company LLC
    Microlin Bio Inc
    Mithridion Inc
    Mitochon Pharmaceuticals Inc
    Mitsubishi Tanabe Pharma Corp
    ModGene Pharma LLC
    NAL Pharmaceuticals Ltd
    Nanomerics Ltd
    Nanotherapeutics Inc
    Neuralstem Inc
    Neuraltus Pharmaceuticals Inc
    Neurim Pharmaceuticals Ltd
    Neuro-Sys SAS
    NeuroGenetic Pharmaceuticals Inc
    NeuroNascent Inc
    NeurOp Inc
    Neuropore Therapies Inc
    Neurotez Inc
    New World Laboratories Inc
    nLife Therapeutics SL
    NLS Pharma Group
    Novartis AG
    NsGene A/S
    Oligomerix inc
    Orphit SAS
    Oryzon Genomics SA
    P2D Bioscience
    Pain Therapeutics Inc
    Palumed SA
    Panacea Pharmaceuticals Inc
    Peptron Inc
    Pfizer Inc
    PharmaKure Ltd
    PharmatrophiX Inc
    Pharmaxis Ltd
    Pharnext SA
    Prevacus Inc
    Probiodrug AG
    Proclara Biosciences Inc
    Progenra Inc
    ProMIS Neurosciences Inc
    ProQR Therapeutics NV
    Proteome Sciences Plc
    Proteostasis Therapeutics Inc
    QR Pharma Inc
    Quimatryx SL
    Radius Health Inc
    Regenera Pharma Ltd
    reMYND NV
    Resverlogix Corp
    Retrotope Inc
    ReXceptor Inc
    Rodos BioTarget GmbH
    Sage Therapeutics Inc
    Samjin Pharmaceutical Co Ltd
    Samumed LLC
    SanBio Inc
    Saneron CCEL Therapeutics Inc
    Sanofi
    SBI Pharmaceuticals Co Ltd
    Selvita SA
    SeneXta Therapeutics SA
    Serometrix LLC
    Signum Biosciences Inc
    Simcere Pharmaceutical Group
    SK Biopharmaceuticals Co Ltd
    SOM Biotech SL
    Spectrum Pharmaceuticals Inc
    Spherium Biomed SL
    Stemedica Cell Technologies Inc
    Sumitomo Dainippon Pharma Co Ltd
    Summit Therapeutics Plc
    Suven Life Sciences Ltd
    T3D Therapeutics Inc
    Takeda Pharmaceutical Company Ltd
    TauRx Therapeutics Ltd
    TechnoPhage SA
    Teijin Pharma Ltd
    Teikoku Pharma USA Inc
    Telocyte LLC
    Tetra Discovery Partners LLC
    Thera Neuropharma Inc
    Theranexus SAS
    Therapix Biosciences Ltd
    Toyama Chemical Co Ltd
    Treventis Corp
    UCB SA
    Varinel Inc
    Virobay Inc
    Vitae Pharmaceuticals Inc
    VLP Therapeutics LLC
    Voyager Therapeutics Inc
    vTv Therapeutics Inc
    Vybion Inc
    Wellstat Therapeutics Corp
    Xigen SA
    Zhejiang Hisun Pharmaceutical Co Ltd

    Request for Sample

    Report Url https://www.reportsweb.com//alzheimers-disease-pipeline-review-h1-2017&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url https://www.reportsweb.com//alzheimers-disease-pipeline-review-h1-2017&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url https://www.reportsweb.com//alzheimers-disease-pipeline-review-h1-2017&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments